On March 20, Governor Phil Bryant signed a house bill authored by Josh Harkins into law that would allow cannabidiol (CBD) oil to be dispensed at the University of Mississippi Medical Center for treatment of various different medical issues.
This was not the first time a bill such as that crossed the Governor’s desk.
In 2014, lawmakers passed “Harper Grace’s Law,” approving the UMMC to dispense CBD oil for the treatment of epileptic seizures in children.
UMMC has released a statement regarding the recently signed bill, the 2014 legislation, and what still has to happen before the CBD oil could be dispensed.
“…UMMC has been working with the University of Mississippi National Center for Natural Products Research to develop and gain regulatory approval to conduct a clinical trial using CBD oil, which is extracted from the marijuana plant’s leaves. It is not to be confused with hemp oil, which is extracted from hemp seeds.
This year, the state legislature amended the original law to allow more pharmacists and labs to formulate CBD, with UMMC’s pharmacy remaining the state’s sole dispensary. That law goes into effect July 1.
However, major federal regulatory requirements still exist before patients can receive the potential treatment in a carefully controlled clinical trial. We do not anticipate that approval by the date the amended law goes into effect.”
There is no anticipated timeline regarding how long it would take to get the federal approval.
Related:
/lawmakers-push-for-cbd-oil-to-be-available-to-patients/
